Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-l) administered in adjuvant system AS01B or AS02A

Michele D. Spring, James F. Cummings, Christian F. Ockenhouse, Sheetij Dutta, Randall Reidler, Evelina Angov, Elke Bergmann-Leitner, V. Ann Stewart, Stacey Bittner, Laure Juompan, Mark G. Kortepeter, Robin Nielsen, Urszula Krzych, Ev Tierney, Lisa A. Ware, Megan Dowler, Cornelus C. Hermsen, Robert W. Sauerwein, Sake J. de Vlas, Opokua Ofori-AnyinamDavid E. Lanar, Jack L. Williams, Kent E. Kester, Kathryn Tucker, Meng Shi, Elissa Malkin, Carole Long, Carter L. Diggs, Lorraine Soisson, Marie Claude Duboiss, W. Ripley Ballou, Joe Cohen, D. Gray Heppner

Research output: Contribution to journalArticle

142 Scopus citations

Fingerprint Dive into the research topics of 'Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-l) administered in adjuvant system AS01B or AS02A'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Chemical Compounds